|
Catalog Number SP-101 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Unspecified Infection (1930); Swelling/ Edema (4577)
|
Event Date 09/07/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
A venaseal closure system was used for treatment of the great saphenous vein (gsv).The ifu was followed.On the (b)(6) 2023, a full-length injection of glue was made into right great saphenous vein (gsv).It was reported post procedure that the wound opening was not covered and the patient was sweating and took a shower.On the (b)(6) 2023 during outpatient visit the wound opened and was stitched again at the outpatient clinic.The dehiscence could not be identified, but at the facility incisions were made in many places other than the blood vessels that are filled with glue when ligating ipv in the lower leg.There is a possibility that the infection occurred due to bacteria entering the wound.On the (b)(6) 2023 during an outpatient visit, the entire leg was red and swollen.Fluid accumulation was observed around the blood vessel clogged with glue and antibiotics were prescribed.As there was no increase in ige, the physician stated that it was not an allergy to the venaseal adhesive.On the (b)(6) 2023 symptoms were improved at outpati ent visit.
|
|
Manufacturer Narrative
|
Additional information: the date of onset symptoms is unknown but was between (b)(6) 2023.The ifu was followed for the location of catheter tip prior to initial delivery of adhesive, the catheter tip was 5cm caudal to sfj and compression of gsv.The right leg will be treated first, and the left leg (cac treatment) will be treated on (b)(6) 2023 (using venaseal).Sterile techniques were followed.It was mentioned from the nurse that the patient did not have dvt.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Image analysis: it is difficult to be certain what the provided images show.They are black and white and therefore color flow doppler is not depicted.There appears to be flow in the cfv.The gsv appears occluded, which corresponds to the history of venaseal treatment.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|